These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 27939801

  • 1. First cases of calcium pyrophosphate deposition disease after zoledronic acid therapy.
    Couture G, Delzor F, Bagheri H, Micallef J, Ruyssen-Witrand A, Laroche M.
    Joint Bone Spine; 2017 Mar; 84(2):213-215. PubMed ID: 27939801
    [Abstract] [Full Text] [Related]

  • 2. Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.
    Sieber P, Lardelli P, Kraenzlin CA, Kraenzlin ME, Meier C.
    Clin Drug Investig; 2013 Feb; 33(2):117-22. PubMed ID: 23184667
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass.
    Hamdy RC.
    Drug Des Devel Ther; 2010 Nov 18; 4():321-35. PubMed ID: 21151620
    [Abstract] [Full Text] [Related]

  • 7. Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis.
    Ding Y, Zeng JC, Yin F, Zhang CL, Zhang Y, Li SX, Liu X, Zhang C, Xue QY, Lin H, Pei FX.
    Orthop Surg; 2017 Aug 18; 9(3):284-289. PubMed ID: 28960821
    [Abstract] [Full Text] [Related]

  • 8. Symptomatic hypocalcemia following intravenous administration of zoledronic acid in a breast cancer patient.
    Mishra A.
    J Postgrad Med; 2008 Aug 18; 54(3):237. PubMed ID: 18626181
    [No Abstract] [Full Text] [Related]

  • 9. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB.
    Ann Pharmacother; 2008 Jul 18; 42(7):1085-9. PubMed ID: 18505912
    [Abstract] [Full Text] [Related]

  • 10. Zoledronic acid: a review of its use in the treatment of osteoporosis.
    Deeks ED, Perry CM.
    Drugs Aging; 2008 Jul 18; 25(11):963-86. PubMed ID: 18947264
    [Abstract] [Full Text] [Related]

  • 11. Medication-related osteonecrosis of the jaws from once per year intravenous zoledronic acid (Reclast): report of 4 cases.
    Lee CY, Suzuki JB.
    Implant Dent; 2015 Apr 18; 24(2):227-31. PubMed ID: 25734948
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of intravenous zoledronic acid in paediatric osteoporosis.
    Brown JJ, Zacharin MR.
    J Pediatr Endocrinol Metab; 2009 Jan 18; 22(1):55-63. PubMed ID: 19344075
    [Abstract] [Full Text] [Related]

  • 14. Undetectable Urine Calcium in a Gastric Bypass Patient.
    Campbell ST, Santen RJ, Bruns DE.
    Clin Chem; 2016 Aug 18; 62(8):1161. PubMed ID: 27471247
    [No Abstract] [Full Text] [Related]

  • 15. Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.
    Prescrire Int; 2008 Aug 18; 17(96):143. PubMed ID: 19480098
    [Abstract] [Full Text] [Related]

  • 16. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Sánchez A, Blanco R.
    Osteoporos Int; 2017 Mar 18; 28(3):1145-1147. PubMed ID: 27866217
    [Abstract] [Full Text] [Related]

  • 17. [Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project].
    Dalle Carbonare L, Bertoldo F, Lo Cascio V.
    Reumatismo; 2009 Mar 18; 61(1):54-64. PubMed ID: 19370189
    [Abstract] [Full Text] [Related]

  • 18. Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid.
    Silverman SL, Kriegman A, Goncalves J, Kianifard F, Carlson T, Leary E.
    Osteoporos Int; 2011 Aug 18; 22(8):2337-45. PubMed ID: 21116816
    [Abstract] [Full Text] [Related]

  • 19. Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience.
    George S, Weber DR, Kaplan P, Hummel K, Monk HM, Levine MA.
    J Clin Endocrinol Metab; 2015 Nov 18; 100(11):4163-71. PubMed ID: 26308295
    [Abstract] [Full Text] [Related]

  • 20. Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis.
    John Camm A.
    Clin Ther; 2010 Mar 18; 32(3):426-36. PubMed ID: 20399982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.